Filing Details
- Accession Number:
- 0000875320-10-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-03 13:00:00
- Reporting Period:
- 2010-08-02
- Filing Date:
- 2010-08-03
- Accepted Time:
- 2010-08-03 12:08:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1349077 | Lisa Kelly | C/O Vertex Pharmaceuticals Incorporated 130 Waverly Street Cambridge MA 02139 | Svp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-08-02 | 307 | $34.17 | 34,256 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan established under Rule 10b5-1.